April 3 (Reuters) - BELLUS Health Inc BLU.TO :
* BELLUS HEALTH ANNOUNCES CLEARANCE OF U.S. IND FOR BLU-5937 PHASE 2 STUDY IN CHRONIC COUGH PATIENTS
* BELLUS HEALTH INC - PHASE 2 STUDY FOR POTENTIAL BEST-IN-CLASS THERAPEUTIC FOR REFRACTORY CHRONIC COUGH PATIENTS EXPECTED TO START IN MID-2019
* BELLUS HEALTH - EXPECTS TOP-LINE RESULTS FOR CLINICAL PHASE 2 STUDY FOR BLU-5937 IN CHRONIC COUGH PATIENT IN MID-2020